Havana, August 4 (RHC) -– Cuban health technology helped screen over seven million Mexican children and provide early detection of congenital conditions in 3,000 babies in that country over the past 14 years of cooperation actions in the field.

The scientific work provided the babies with a higher quality of life, normal neuro-cognitive development and in many cases actually saved their lives, said the deputy director of the Cuba Immunological Assay Center, Aramis Sanchez, in an interview with Cubadebate website.

Sanchez, a biochemist, says that 102 labs in Mexico now count on Cuban technology to detect congenital diseases in newborn children, out of which 61 are under the Mexican Social Security Institute.

Mexico is a country with large imports of the Cuba-made SUMA technology or Ultra-Micro Analytical System, being produced by the Immunological Assay Center, which is under the new entrepreneurial group BioCubaFarma.

Official statistics say that about two million children are born every year in Mexico, with half a million running the risk of suffering from a disability at birth or of living with long-term effects. From these, between 100 to 200 thousand young children suffer from a congenital condition.

As part of its medical collaboration with Mexico, Cuban professionals train Mexican specialists and offers immediate technical assistance.